XLV vs IBRN
YTDYear to date
XLV wins+19.2 pts
Past year
XLV wins+13.7 pts
Fee
XLV winslower fee
Yield
XLV wins+0.4 pts
AUM
XLV7774.9× more
4–0XLV wins
XLV and IBRN · year-to-date · as of Nov 6, 2026 · AUM not scored
| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.9% | +20.9% | $50.9B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.7% | +19.7% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +21.8% | +21.8% | $10.9B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +20.3% | +20.3% | $4.7B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.2% | +19.7% | +19.7% | $4.6B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −2.7% | −2.7% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +20.0% | +20.0% | $4.0B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +54.0% | +54.0% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.4% | +25.6% | +25.6% | $1.6B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.9% | +24.9% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +22.8% | +22.8% | $1.2B | |
| 12 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +22.1% | +22.1% | $1.2B | |
| 13 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +31.5% | +31.5% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.4% | +17.4% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +21.9% | +21.9% | $598M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +32.6% | +32.6% | $519M |
| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | −2.5% | +20.9% | +29.6% | $50.9B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | −2.9% | +19.7% | +28.0% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | −6.7% | +21.8% | +37.9% | $10.9B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −2.8% | +20.3% | +28.8% | $4.7B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.2% | +3.2% | +19.7% | +28.6% | $4.6B | |
| 6 | IBRN | iShares Neuroscience and Healthcare ETFThis fund | 0.47% | 1.0% | −3.2% | +1.8% | +15.9% | $6.6M |